TP53 and osteosarcoma: In contrast, an analysis of 196 patients with high-grade osteosarcoma demonstrated that the prognosis of patients with p53 mutations is only slightly worse than those with the wild-type gene; a relationship between the p53 status and systemic relapse was not identified, and a p53 mutation did not predict the development of metastasis [17].